| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.05 |